{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Baltimore",
      "state": "MD",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA090034"
        ],
        "brand_name": [
          "RIFAMPIN"
        ],
        "generic_name": [
          "RIFAMPIN"
        ],
        "manufacturer_name": [
          "Lupin Pharmaceuticals, Inc."
        ],
        "product_ndc": [
          "68180-658",
          "68180-659"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "RIFAMPIN"
        ],
        "rxcui": [
          "198201",
          "198202"
        ],
        "spl_id": [
          "5ed1edac-e11e-4f87-b390-e770a69a9b37"
        ],
        "spl_set_id": [
          "b56004f0-f23d-47f6-80c7-39884fccbccc"
        ],
        "package_ndc": [
          "68180-658-06",
          "68180-658-01",
          "68180-659-06",
          "68180-659-07",
          "68180-659-01"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175500",
          "M0019113"
        ],
        "pharm_class_epc": [
          "Rifamycin Antibacterial [EPC]"
        ],
        "pharm_class_cs": [
          "Rifamycins [CS]"
        ],
        "unii": [
          "VJT6J7R4TR"
        ]
      },
      "product_type": "Drugs",
      "event_id": "90616",
      "recalling_firm": "Lupin Pharmaceuticals Inc.",
      "address_1": "Harborplace Tower",
      "address_2": "111 S Calvert St Fl 21st",
      "postal_code": "21202-6174",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed nationwide.",
      "recall_number": "D-1343-2022",
      "product_description": "Rifampin Capsules, USP, 150 mg, 30 count HDPE bottles, Rx Only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, 21202  NDC: 68180-658-06",
      "product_quantity": "7,872/30 count bottles",
      "reason_for_recall": "CGMP Deviations:OOS result was observed in 1-Methyl-4-Nitroso Piperazine (MNP) impurity.",
      "recall_initiation_date": "20220728",
      "center_classification_date": "20220816",
      "termination_date": "20231005",
      "report_date": "20220824",
      "code_info": "Lot #A200170, exp. date December 2023",
      "more_code_info": ""
    }
  ]
}